Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation

Introduction: F-18-fluoroglycosylation via oxime formation is a chemoselective and mild radiolabeling method for sensitive molecules. Glycosylation can also improve the bioavailability, in vivo kinetics, and stability of the compound in blood, as well as accelerate clearance of biomolecules. A typical synthesis procedure for F-18-fluoroglycosylation with [F-18]FDG (2-deoxy-2-[F-18]fluoro-D-glucose) and [F-18]FDR (5-deoxy-5[F-18]fluoro-D-ribose) involves two HPLC (high performance liquid chromatography) purifications: one after F-18-fluorination of the carbohydrate to remove its labeling precursor, and a second one after the oxime formation step to remove the aminooxy precursor. The two HPLC purifications can be time consuming and complicate the adaptation of the synthetic strategy in nuclear medicine applications and automated synthesis. We have developed a procedure in which SPE (solid phase extraction) and resin purification methods replace both of the needed HPLC purification steps. Methods: We used [F-18]FDR and [F-18]FDG as prosthetic groups to radiolabel two aminooxy-modified model molecules, a tetrazine and a PSMA (prostate specific membrane antigen) inhibitor. After fluorination, the excess carbohydrate precursor was removed by derivatizing it with 4,4'-dimethoxytrityl chloride (DMT-CI). The DMT moiety increases the hydrophobicity of the unreacted precursor making the separation from the fluorinated precursor possible with simple C18 Sep-Pak cartridge. For removal of the aminooxy precursor, we used a commercially available aldehyde resin (AminoLink, Thermo Fisher Scientific). C18 Sep-Pak SPE cartridge was used to separate [F-18]FDR and [F-18]FDG from the F-18-fluoroglycoconjugate end product. Results: [F-18]FDR and [F-18]FDG were efficiently purified from their precursors, free fluorine-18, and other impurities. The aldehyde resin quantitatively removed the unreacted aminooxy precursors after the oxime formation. The fluorine-18 labeled oxime end products were obtained with high radiochemical purity (>99%) and molar activity (>600 GBq mu mol(-1)). Conclusions: We have developed an efficient cartridge purification method for producing high molar activity F-18-glycoconjugates synthesized via oxime formation. (C) 2018 Elsevier Inc. All rights reserved.